Actos and Bladder Cancer
Patients who use the diabetes drug Actos for more than one year are more likely to develop bladder cancer than diabetics taking other drugs, according to a June 2011 warning by the Food and Drug Administration. Patients who were prescribed the highest doses of Actos were also found to have an increased bladder cancer risk.
The FDA has added information to the prescribing information issued to doctors about the increased risk of bladder cancer for Actos users. The agency has also added a warning about Actos and bladder cancer to the medication guide given to patients who are prescribed the drug.
Estimates vary as to how much more likely Actos patients may be to develop bladder cancer. A French study found that Actos users were 22% more likely to be diagnosed with bladder cancer than other diabetes drug users—prompting health officials in France and Germany to recall the drug. According to a recent study in the journal Diabetes Care, patients who took Actos for two years or more are 40% more likely to develop bladder cancer.
The FDA’s warning about Actos advised patients to talk with their doctors if they develop any of the symptoms of bladder cancer while taking the drug, including blood or red color in the urine, an urgent need to go to the bathroom, pain while urinating, back pair or abdominal pain.
If you or a loved one used Actos and were diagnosed with bladder cancer—or have developed any symptoms of this disease—you may be eligible to file a lawsuit. For a free legal evaluation, contact the lawyers at Hissey Kientz, LLP by calling our toll-free number at 1-866-275-4454, or by filling out the free case evaluation form located on this page.